(XZEM) Xtrackers MSCI Emerging - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: IE00BG370F43 • Global Emerging Markets Equity

XZEM: Stocks, Bonds, Emerging Markets, Equities

Xtrackers MSCI Emerging Markets ESG UCITS ETF 1C (XETRA:XZEM) is a Germany-domiciled ETF designed to offer exposure to emerging markets with a focus on environmental, social, and governance (ESG) criteria. Listed on XETRA, it provides investors with a diversified portfolio of emerging market equities that meet specific ESG standards, filtered through the Morningstar EM TME NR USD index.

With an AUM of 1634.46M EUR, this ETF is part of the broader Xtrackers suite, known for its transparency and tracking efficiency. It is structured as a UCITS-compliant fund, which ensures adherence to European regulatory standards, offering a layer of investor protection and operational clarity. The fund tracks the Morningstar Emerging Markets Target Market Exposure Net Return USD index, which is designed to capture the performance of emerging market equities while applying ESG filters to exclude companies that do not meet certain sustainability criteria.

For investors and fund managers, this ETF is notable for its ESG focus, which aligns with the growing demand for sustainable investing. It offers a cost-effective way to gain exposure to a diversified basket of emerging market equities while adhering to ESG principles. The fund’s structure allows for liquidity and ease of trading on the XETRA exchange, making it accessible to both institutional and retail investors. Additionally, the ETF’s ESG screens may help investors mitigate certain risks associated with non-ESG compliant companies, though it’s important to evaluate how these screens are applied and their potential impact on performance.

The fund’s expense ratio and tracking difference are critical metrics for evaluating its efficiency. While the description does not specify these figures, they are essential for investors assessing the ETF’s cost-effectiveness and ability to deliver returns in line with its underlying index. As with any ETF, understanding the index methodology, including the specific ESG criteria used, is crucial for aligning the investment with individual or institutional objectives.

Additional Sources for XZEM ETF

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

XZEM ETF Overview

Market Cap in USD 1,772m
Category Global Emerging Markets Equity
TER 0.25%
IPO / Inception 2019-10-15

XZEM ETF Ratings

Growth 5y 21.3%
Fundamental -
Dividend 0.0%
Rel. Strength Industry -9.44
Analysts -
Fair Price Momentum 41.87 EUR
Fair Price DCF -

XZEM Dividends

No Dividends Paid

XZEM Growth Ratios

Growth Correlation 3m 44.8%
Growth Correlation 12m 87.1%
Growth Correlation 5y -28.5%
CAGR 5y 6.56%
CAGR/Max DD 5y 0.18
Sharpe Ratio 12m 1.57
Alpha 7.35
Beta 0.74
Volatility 19.08%
Current Volume 0.6k
Average Volume 20d 4.3k
What is the price of XZEM stocks?
As of March 14, 2025, the stock is trading at EUR 46.30 with a total of 576 shares traded.
Over the past week, the price has changed by -2.81%, over one month by -5.47%, over three months by -2.20% and over the past year by +13.04%.
Is Xtrackers MSCI Emerging a good stock to buy?
Neither. Based on ValueRay Analyses, Xtrackers MSCI Emerging is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 21.25 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of XZEM as of March 2025 is 41.87. This means that XZEM is currently overvalued and has a potential downside of -9.57%.
Is XZEM a buy, sell or hold?
Xtrackers MSCI Emerging has no consensus analysts rating.
What are the forecast for XZEM stock price target?
According to ValueRays Forecast Model, XZEM Xtrackers MSCI Emerging will be worth about 46.6 in March 2026. The stock is currently trading at 46.30. This means that the stock has a potential upside of +0.67%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 46.6 0.7%